protease

Interviews and expert commentary tagged “protease” — the latest oncology research and clinical practice from the Audio Journal of Oncology.

Three-Class Antiretroviral Therapy for HIV Not Appropriate: Results from the FIRST Study
Audio Journal of Oncology

Three-Class Antiretroviral Therapy for HIV Not Appropriate: Results from the FIRST Study

RODGER MACARTHUR, Wayne State University, Detroit REFERENCE: Lancet 2006; 368: 2125-35 A three-class HIV antiretroviral therapy is not necessary, according to data published in the Lancet. The FIRST s

19 January 2007
0:00
New Protease Inhibitor for HIV Patients with Few Options
Audio Journal of Oncology

New Protease Inhibitor for HIV Patients with Few Options

Timothy Wilkin Timothy Wilkin, Weill Cornell Medical College, New York A protease inhibitor, currently known as TMC114 has been tested in the POWER II study among some 300 patients who had failed mult

6 January 2006
0:00